Triazolam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Triazolam.
| Product ID | 50090-4733_2f2e5af4-5f57-44f2-92b9-b58170ec03cc |
| NDC | 50090-4733 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Triazolam |
| Generic Name | Triazolam |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-10-29 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074224 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | TRIAZOLAM |
| Active Ingredient Strength | 0 mg/1 |
| Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-11-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-11-18 |
| Marketing Category | ANDA |
| Application Number | ANDA074224 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-11-18 |
| Ingredient | Strength |
|---|---|
| TRIAZOLAM | .25 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-4858 | Triazolam | Triazolam |
| 0054-4859 | Triazolam | Triazolam |
| 21695-284 | Triazolam | Triazolam |
| 21695-303 | Triazolam | Triazolam |
| 43063-996 | Triazolam | Triazolam |
| 43353-451 | Triazolam | triazolam |
| 50090-0522 | Triazolam | triazolam |
| 50090-4733 | Triazolam | Triazolam |
| 50436-3718 | Triazolam | triazolam |
| 50742-645 | Triazolam | Triazolam |
| 50742-646 | Triazolam | Triazolam |
| 55289-787 | Triazolam | triazolam |
| 59762-3717 | Triazolam | triazolam |
| 59762-3718 | Triazolam | triazolam |
| 67544-725 | Triazolam | Triazolam |
| 63629-2956 | Triazolam | Triazolam |
| 0009-0017 | Halcion | triazolam |